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Objectives: To analyze the prevalence of Calciﬁc Aortic Valve Disease (CAVD) in
the Chinese population.
Methods: Data was collected from Echocardiogram reports of subjects who had been
examined in the Cardiology Department of our hospital spanning a period of eight
years; from January 2005 to December 2012.The data collected was then analyzed
using statistical methods Independent t Test and Chi Square tests of SPSS 13.0 of IBM
SPSS Statistics. The level of signiﬁcance was set at 99% Conﬁdence Interval.
Results: The total number of subjects aged 45 years was (n¼17826), men (n¼9725,
54.6%). The estimated prevalence in our study subjects for individuals 45 years and
older was 12.8% (99% CI, 12.1%-13.4%), the estimated prevalence among men was
13.6% (99%, 12.7%-14.5%) and that among women was 11.9% (99%CI, 11%-
12.8%). The mean age of prevalence for men was (7010) years and for women was
(71 10) years. We observed a dramatic increase of prevalence with advancing age,
the four age groups 45-64, 65-74, 75-84 and 85 years old or older, had the prevalence
of 5.3%, 20.5% 32.9% and 54.4% respectively. For individuals aged 65 years and
older the estimated prevalence was 25.7% approximately equivalent to that estimated
in the western population. At the time of examination, stenosis ranging from mild to
severe had already set in 15% of those with CAVD. Regurgitation of the aortic valves
was the most frequent functional abnormality observed and the most frequent involved
leaﬂet was the noncoronary valve leaﬂet. Hypertension had the closest association
with CAVD, 27% of subjects in the CAVD group were hypertensive. A signiﬁcant
association was also observed between CAVD and CHD.
Conclusions: This study shows that, prevalence of CAVD in the Chinese population
does not differ from that already observed in the Western population, the prevalence of
CAVD showed a signiﬁcant increase as age increases. Hypertension has a closest
association with CAVD; therefore effective control of hypertension may help delay
the onset or control the progression of CAVD.
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Objectives: Junctophilin-2 (JP2) is a membrane-binding protein coupling between
plasma membrane L-type Ca2+ channels and sarcoplasmic reticular ryanodine re-
ceptors (Ryr) in cardiac myocytes which regulate intracellular calcium stability.
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal
intracellular calcium-handling. The aim of this study was to investigate whether the
changes of JPH2 contributes to the development of atrial ﬁbrillation (AF).
Methods: The mRNA level of JP2 was assayed by quantitative polymerase chain
reaction and the protein level of JP2 was determined using western blot analysis (12
atrial appendages from patients with sinus rhythm (SR) and 24 atrial appendages from
patients with Chronic AF (CAF).
Results: Our results identiﬁed that the JP2 protein was expressed in patients atrial
both in SR and CAF. The mRNA level was down-regulation in Patients atrial with
CAF (n¼24, P<0.01) compared with SR (n¼12). Consistent with the mRNA level,
the protein level of JP2 in CAF (n¼24) was decreased signiﬁcantly (P<0.01) than in
SR (n¼12). Our results showed that JP2 reduced the express in mRNA level and
protein level in patients with CAF.
Conclusions: Reduced levels of JP2 may contribute to excitation-contraction coupling
dysfunction in CAF, which induce abnormal intracellular calcium handling during AF.
Therefore, JP2 maybe as a new therapeutic strategy of patients with Atrial Fibrillation.
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Objectives: To determine the frequency of short term clinical outcomes of percuta-
neous transvenous mitral commissurotomy for mitral stenosis among patients having
wilkin score of <12.
Methods: This was a descriptive cross sectional study carried out at Cardiology Unit
Govt. Lady Reading Hospital Peshawar. Duration of study was nine months and
twenty days (July 01, 2012 - June 20, 2013) .Mitral stenosis patients with or without
pre existing mild mitral regurgitation admitted in Cardiology Unit, Lady Reading
Hospital Peshawar were included in the study. After performing PTMC according to
standard protocol, data regarding improvement in mitral valve area, pulmonary artery
pressure and severity of mitral regurgitation was recorded.
Results: Out of total 175 patients 56 (32%) were males. The mean age of the patients
was 22.697.93 years. Mean BMI of patients was 21.073.95. Mean Wilkin’s score
was 6.691.99 ranging from 3-11. Improvement in mitral valve area, pulmonary
artery pressure, mitral valve gradient and left atrial volume were found in 148 (84.6%) ,
170 (97.1%) , 175 (100%) and 170 (97.1%) respectively. While worsening in mitral
regurgitation was 47 (26.9%).
Conclusions: PTMC is a safe and effective procedure with good short term outcomes
like improvement in mitral valve area, pulmonary artery pressure, mitral valve
gradient and left atrial volume and not worsening mitral regurgitations in patients of
mitral stenosis having Wilkin’s score < 12.C196 JACC Vol 64/16/Suppl C j October 16–1Cardiomyopathy
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Objectives: In 1984, Fu Wai Hospital pioneered the surgical treatment of hypertro-
phic obstructive cardiomyopathy (HOCM) in China. In 2002 we evolved our septal
myectomy technique with wider septal resection to the base of both papillary muscles
without mitral valve leaﬂets treatment. This study was conducted to evaluate follow-
up Results in patients with HOCM who underwent modiﬁed Morrow procedure in
China.
Methods: Between 2002 and 2014, a total of 201 consecutive HOCM patients who
underwent modiﬁed Morrow procedure by the author in Fu Wai Hospital were
retrospectively recruited. The clinical effects were evaluated during the follow-up
period.
Results: Among 201 patients, 142 patients were treated with isolated modiﬁed
Morrow procedure, 59 patients who had other cardiac lesions underwent modiﬁed
Morrow procedure simultaneous associated cardiac procedures, including coronary
artery bypass graft, cardiac valve repair and replacement, repair of congenital heart
disease, radiofrequency ablation for atrial ﬁbrillation, right ventricular outﬂow tract
reconstruction and cardiac tumor resection. None of the patients died during the
operation. Cardiopulmonary bypass time was (85.231.1) minutes and aortic
clamping time was (55.221.2) minutes. The width, length and thickness of excised
septal myocardium were (43.29.3) mm, (44.48.5) mm and (11.02.7) mm,
respectively. After the operation, the left ventricular outﬂow tract (LVOT) pressure
gradient decreased from (92.230.4) mmHg to (16.09.9) mmHg (P<0.001). Mitral
regurgitation was signiﬁcantly improved, and 198 cases were trivial or no regurgita-
tion (P< 0.001). There were 6 (3%) patients received permanent pacemaker im-
plantation because of complete atrial-ventricular block, 3 (1.5%) underwent
concurrent ventricular septal perforation repair, 1 underwent apical anterior wall
perforation repair. 136 patients were followed-up (3 to 141 months) . During this
period, the average LVOT pressure gradient was at (14. 111.8) mmHg. 109 patients
were out of symptoms and were able to engage in daily housework or return to work.
The post-operative NYHA signiﬁcantly improved to (1.20.5) compared with
(2.90.4) preoperatively (P<0.001). HOCM related events were 4% including 4
patients of AF, 2 patients of myocardial ischemia, 1 patient of heart failure (HF), 1
patient of stroke accompanying HF with re-hospitalization. 1 patient died of Stanford
type A aortic dissection rupture 57 months after the operation.
Conclusions: Modiﬁed Morrow procedure across the aortic incision was an effective
treatment for HOCM. To excise thoroughly hypertrophic septal myocardium and
released papillary muscle were the key to improve the efﬁcacy of this operation.
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Objectives: Frequent premature ventricular complexes (PVCs) are associated with
left ventricular (LV) dysfunction. We performed a meta-analysis to evaluate the
effects of catheter ablation on improvement of LV function in patients with
frequent PVCs.
Methods: We searched MEDLINE for cohort studies of patients who underwent
catheter ablation of frequent PVCs. LV ejection fraction (LVEF) both before and
post-ablation was reported. The endpoints were changes from baseline in LVEF post-
ablation. Subgroup analysis of patients with LV dysfunction at baseline was
performed. Quantitative analysis of continuous variables was performed according to
random-effect Methods by MetaAnalyst Beta3.13 software. A 5% absolute increase
borderline in LVEF post-ablation for clinically signiﬁcance was prespeciﬁed. If the
lower limit of 95%CI of the overall mean change in LVEF post-ablation was beyond
the prespeciﬁed borderline, the effect of PVC ablation on LV function improvement
would be considered clinically signiﬁcant by 1-tailed student t test (0.05).
Results: Fifteen studies with 712 patients were included. The mean PVC burden
before catheter ablation was 24% [95% conﬁdence intervals (CIs): 19%–29%]. The
long-term success rate of PVC ablation ranged from 66%–90%. The overall mean
increase from baseline in LVEF post-ablation was 7.7% (95%CI: 6.1%–9.4%). The
student’s t test showed that the overall mean change in LVEF was beyond the
borderline of signiﬁcance (t value ¼ 3.23, p<0.05, Figure A). Subgroup analysis
showed that the overall mean increase from baseline in LVEF post-ablation was
12.4% (95%CI: 8.1%–16.6%) in patients with LV dysfunction at baseline. The stu-
dent’s t test showed that the overall mean change of LVEF in patients with LV
dysfunction at baseline was beyond the borderline of signiﬁcance (t value ¼ 3.44,
p<0.05, Figure B).9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
